Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06022029
Title A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (ON-5001)
Acronym ON-5001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoNano Medicine, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
California Research Institute RECRUITING Los Angeles California 90027 United States Details
BRCR Global RECRUITING Tamarac Florida 33321 United States Details
Gabrail Cancer Center Research RECRUITING Canton Ohio 44718 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
Allegheny Health Network RECRUITING Pittsburgh Pennsylvania 15224 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
University of Texas Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Virginia Cancer Specialists, PC RECRUITING Fairfax Virginia 22031 United States Details
Cancer Care Wollongong RECRUITING Wollongong New South Wales 2500 Australia Details
Tasman Oncology Research RECRUITING Southport Queensland 4215 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field